FemTech Startups

Overture develops automation and technology to improve fertility treatment, aiming to lower costs and increase success rates. It targets the fertility care market and the people undergoing such treatment.

8 investors

Proov offers at-home hormone and fertility testing products, including systems to identify the fertile window, confirm ovulation, and screen for leading causes of infertility, paired with an app providing hormone insights and personalized recommendations. It serves women tracking their fertility and reproductive wellness.

8 investors

Sequel manufactures re-engineered spiral-design tampons with patented technology for improved absorption and leak prevention. The products are FDA-cleared medical devices designed and founded by female engineers and athletes.

8 investors

The Flex Co. makes sustainable menstrual products, including menstrual discs and cups sold direct-to-consumer online and through over 30,000 U.S. retail stores such as Walmart, Target, CVS, and Walgreens. It designs and manufactures its own period care products in the U.S. and Canada.

8 investors

Womaness makes Melt For You, hormone-free vaginal inserts that melt at body temperature to release medical-grade hyaluronic acid, marketed to women experiencing vaginal dryness, irritation, or discomfort during intimacy. The applicator-free suppositories are a consumer wellness product in the menopause and women's intimate health category.

8 investors

Aavia is a mobile app that helps people with ovaries track and understand how their hormones impact their health, mood, and productivity. The app provides personalized insights, science-backed recommendations, and educational content developed with reproductive health specialists.

7 investors

Bellabeat develops AI-powered wearable devices and a health intelligence platform designed to help women track wellness metrics, understand hormonal cycles, and receive personalized health insights. The company targets women seeking preventive care and longevity optimization through cycle-based data analysis and biometric monitoring.

7 investors

BeSound provides radiation-free breast ultrasound imaging with AI-powered detection, aimed at women — particularly those with dense breast tissue — who may be underserved by mammography. It operates a physical clinic in Los Angeles and a planned mobile unit, offering 20-minute scans with results in 24-48 hours.

7 investors

Female Invest is an educational platform providing an investment dictionary and learning resources for retail investors, particularly women interested in financial literacy and investing.

7 investors

Flo is a women's health app offering personalized cycle tracking, fertility guidance, pregnancy support, and health education backed by a medical team. The app serves women and people with periods globally with science-based insights on hormonal health from first period to perimenopause.

7 investors

Gaia offers fixed-price IVF and fertility treatment plans in the U.S., bundling costs into one price with monthly payment options, unlimited embryo transfers, and guaranteed minimum egg counts. It partners with a network of over 180 fertility clinics and provides members with support from nurses, therapists, nutritionists, and advocates, serving hopeful parents, single parents, LGBTQIA+ families, and people freezing eggs.

7 investors

Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis. Its pipeline targets inflammation- and pain-related conditions across clinical development stages.

7 investors

Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists. The company focuses on women's health and pelvic floor rehabilitation.

7 investors

Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.

7 investors

Inito offers an at-home device and app for women to track fertility hormones, supporting fertility monitoring and self-care. The company is based in India and operates in the women's health and digital health space.

7 investors

iSono Health develops an automated 3D ultrasound scanner paired with cloud computation and machine learning to detect and monitor breast cancer. The platform targets women and healthcare providers for point-of-care diagnostics and at-home, walk-in, and mobile clinic breast health monitoring.

7 investors

Lola sells feminine care and sexual health products, including 100% cotton tampons, pads, and condoms, sold directly to consumers. Its offerings are marketed for women managing menstruation and reproductive wellness.

7 investors

Madorra develops a nonhormonal, noninvasive medical device to treat vaginal dryness and vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors. The company operates in the women's health medical device sector and has received FDA breakthrough device designation.

7 investors

Materna Medical develops medical technologies to address pelvic health needs in obstetrics and gynecology. The company serves women's healthcare and operates in the medtech sector, headquartered in Mountain View, California.

7 investors

Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical. The platform serves pregnant women and their healthcare providers to improve maternal and fetal health outcomes.

7 investors

Nadia Care provides maternity support during pregnancy and after birth, pairing members with maternity coaches and a care team for prenatal, labor, feeding, nutritional, mental health, and postpartum help. It works alongside members' doctors and connects them to local community resources such as housing and transportation.

7 investors

Orchid offers whole genome sequencing-based genetic screening of embryos during IVF as well as preconception testing for couples, analyzing DNA to identify predispositions to monogenic diseases, chromosomal abnormalities, and polygenic risks. It serves prospective parents and IVF patients, delivering reports reviewed by board-certified genetic counselors.

7 investors

Ovia Health provides digital health tools and clinical programs for reproductive and family health, including fertility, pregnancy, and parenthood support. The platform delivers personalized coaching, health pathways, and risk identification to help families across their health journey.

7 investors

Persephone Biosciences develops live biotherapeutic products that modulate the metabolism of gut microbes for disease prevention and treatment, with a focus on cancer. It applies systems and synthetic biology to study the gut microbiome.

7 investors